原发性胆汁性肝硬化的治疗进展及误诊原因分析

张波; 陆雁; 曹弘; 胡泰红

原发性胆汁性肝硬化的治疗进展及误诊原因分析

无锡市传染病医院

基金项目:

无锡市科技局项目(社会发展)(CSZ00951)；

详细信息

中图分类号: R575.22
计量
- 文章访问数: 3067
- HTML全文浏览量: 8
- PDF下载量: 855
- 被引次数: 0
出版历程
- 出版日期: 2010-04-20

Progress in treatment and misdiagnosis of primary biliary cirrhosis

Research funding:

摘要

HTML全文

参考文献(13)

[1]James OFW, Bhopal R, Howel D, et al.Primary biliary cirrhosisonce rare, now common in the united kingdom[J].Hepatology, 1999, 30 (2) ∶390-394.

[2]Heathcote EJ.Management of primary biliary cirrhosis.The Americanassociation for the study of liver diseases practice guide-lines[J].Hepatology, 2000, 31 (4) ∶1005-1013.

[3]罗红春, 梅浙川.原发性胆汁性肝硬化的治疗进展[J].国际消化病杂志, 2008, 28 (1) ∶60-62.

[4]王宝恩.重视原发性胆汁性肝硬化的研究[J].肝脏, 2002, 7 (3) ∶145-147.

[5]姚光弼.中国人原发性胆汁性肝硬化的前瞻性研究[J].肝脏, 2002, 7 (3) ∶146-148.

[6]Oo YH, Neuberger J.Options for t reatment of primary biliary cir-rhosis[J].Drugs, 2004, 64 (20) ∶2261-2271.

[7]Kolidinger R.Treatment of primary biliary cirrhosis withcolchicines[J].Gastroenterology, 1980, 78 (5) ∶1309-1311.

[8]Akbar SM, Furukawa S, Nakanishi S, et al.Therapeutic efficacy ofdecreased nit rite production by bezafibrate in patients with primarybiliary cirrhosis[J].Gastroenterology, 2005, 40 (2) ∶157-163.

[9]Kanda T, Yokosuka O, Imazeki F, et al.Bezafibrate treatment:anew medical approach for PBC patients[J].Gastroenterology, 2003, 38 (6) ∶573-578.

[10]Angulo P, Dickson ER.The timing of liver transplantation in pri-mary biliary cirrhosis[J].Baillieres Best Pract Res Clin Gastroen-terol, 2000, 14 (4) ∶657-668.

[11]初玉琳, 刘双燕, 王秀娟.原发性胆汁性肝硬化的诊治教训[J].中国民康医学, 2007, 19 (8) ∶306-308.

[12]Tsuji K, Watanabe Y, Van de water J, et al.Familial primary biliarycirrhosis in Hiroshima[J].Autoimmuinity, 1999, 13 (1) ∶171-178.

[13]Jones DEJ, Watt FE, Metcalf V, et al.Familial primary biliary cir-rhosis reassessed:a geographically-based population study[J].Hepatol, 1999, 30 (3) ∶402-407.

施引文献

资源附件(0)

访问统计